Intrinsic value of Janus Henderson Contrarian Fund - T Shares (JSVAX)

Live fair value data for Janus Henderson Contrarian Fund - T Shares (JSVAX) is currently unavailable. Please check again shortly.

Fallback estimate (fair value API unavailable)

Intrinsic Value (Fair Value): Unlock fair value

Upside: +4.0%

Margin of Safety: +3.8%

Current Price: $316.00

Valuation: Undervalued

Confidence: 4.0/10

Visual Bar

Market Price $316.00Intrinsic Value Locked

Undervalued ✅Fair Value ⚖️Overvalued ❌

This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.

Is Janus Henderson Contrarian Fund - T Shares (JSVAX) undervalued or overvalued?

Based on the current model output, Janus Henderson Contrarian Fund - T Shares appears to be undervalued with a upside of 4.00%.

Fair value vs market price — Janus Henderson Contrarian Fund - T Shares (JSVAX)

Unlock premium access to view the live fair value comparison against current market price for JSVAX.

Unlock Fair Value

Frequently Asked Questions - JSVAX

How is JSVAX intrinsic value estimated?

We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for JSVAX.

Is JSVAX undervalued or overvalued right now?

JSVAX is currently shown as undervalued based on the difference between market price and intrinsic value.

How should I use the confidence score?

The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.

Related companies — intrinsic value

Peers for JSVAX: open their intrinsic value pages.

Explore Other Stocks

AAPL TSLA NVDA MSFT